Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01904 | 34565785 | Korean J Gastroenterol | Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01922 | 34560854 | Cardiovasc Diabetol | Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study. | 2021 | Details |
| A01937 | 34558835 | Hepatol Commun | Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD. | 2021 | Details |
| A01938 | 34558829 | Hepatol Commun | Poor Awareness of Liver Disease Among Adults With NAFLD in the United States. | 2021 | Details |
| A01948 | 34557367 | Cureus | Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. | 2021 | Details |
| A01957 | 34553836 | Obesity (Silver Spring) | Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A01959 | 34552789 | Arab J Urol | Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study. | 2021 | Details |
| A01962 | 34551612 | Future Med Chem | Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2/RAGE/NF-κB signaling pathway. | 2021 | Details |
| A01964 | 34550043 | Adipocyte | Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice. | 2021 | Details |
| A01968 | 34548787 | Clin Interv Aging | NAFLD in the Elderly. | 2021 | Details |
| A01996 | 34535644 | Nat Commun | A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. | 2021 | Details |
| A01999 | 34534894 | Clin Nutr | Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease. | 2021 | Details |
| A02015 | 34530527 | Clin Mol Hepatol | Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. | 2021 | Details |
| A02041 | 34522873 | EClinicalMedicine | Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART). | 2021 | Details |
| A02059 | 34517014 | Metabolism | Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes. | 2021 | Details |
| A02061 | 34516586 | PLoS One | The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus. | 2021 | Details |
| A02071 | 34511822 | J Clin Exp Hepatol | Hepatogenous Diabetes: A Primer. | 2021 | Details |
| A02085 | 34510514 | Hepatology | Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice. | 2021 | Details |
| A02096 | 34508671 | Lancet Gastroenterol Hepatol | Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02097 | 34508669 | Lancet Gastroenterol Hepatol | Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02098 | 34508601 | J Clin Endocrinol Metab | Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. | 2022 | Details |
| A02115 | 34501590 | Int J Environ Res Public Health | Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study. | 2021 | Details |
| A02122 | 34498413 | Pediatr Obes | Recent advances in the epidemiology of nonalcoholic fatty liver disease in children. | 2021 | Details |
| A02151 | 34485209 | Front Public Health | Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study. | 2021 | Details |
| A02170 | 34475908 | Pak J Med Sci | Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors. | 2022 | Details |
| A02175 | 34474517 | Endocrinol Metab (Seoul) | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. | 2021 | Details |
| A02180 | 34472680 | Diabetes Obes Metab | Associations of weight loss with obesity-related comorbidities in a large integrated health system. | 2021 | Details |
| A02181 | 34471049 | Biol Pharm Bull | Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist. | 2021 | Details |
| A02183 | 34470931 | Nihon Yakurigaku Zasshi | [Development of liver organoids from NASH model mice and their application to drug discovery]. | 2021 | Details |
| A02187 | 34469404 | J Clin Gastroenterol | Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. | 2021 | Details |
| A02188 | 34467980 | J Clin Endocrinol Metab | Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study. | 2022 | Details |
| A02190 | 34466796 | JHEP Rep | Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosis. | 2021 | Details |
| A02191 | 34466334 | Cureus | Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program. | 2021 | Details |
| A02192 | 34466320 | Cureus | The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02196 | 34464909 | Diabetes Metab Syndr | Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. | 2021 | Details |
| A02204 | 34461220 | Pharmacol Res | Identification of the anti-fungal drug fenticonazole nitrate as a novel PPARγ-modulating ligand with good therapeutic index: Structure-based screening and biological validation. | 2021 | Details |
| A02216 | 34456329 | Med Sci Monit | A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. | 2021 | Details |
| A02225 | 34453940 | Life Sci | Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning. | 2021 | Details |
| A02228 | 34453359 | Hepatology | Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. | 2021 | Details |
| A02234 | 34450194 | Prog Lipid Res | PARPs in lipid metabolism and related diseases. | 2021 | Details |
| A02248 | 34447235 | World J Gastroenterol | Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. | 2021 | Details |
| A02250 | 34446275 | Maturitas | The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. | 2021 | Details |
| A02251 | 34446271 | Clin Ther | Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02252 | 34446090 | Diabetol Metab Syndr | Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes. | 2021 | Details |
| A02257 | 34445384 | Int J Mol Sci | The Obscure Effect of Tribulus terrestris Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes Mellitus. | 2021 | Details |
| A02262 | 34444750 | Nutrients | Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. | 2021 | Details |
| A02268 | 34441028 | Medicina (Kaunas) | Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. | 2021 | Details |
| A02274 | 34440543 | Life (Basel) | Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis. | 2021 | Details |
| A02292 | 34434058 | Int J Gen Med | Elevated Serum Cyclophilin D Level is Associated with Nonalcoholic Fatty Liver Disease and Higher Fibrosis Scores in Patients with Diabetes Mellitus. | 2021 | Details |
| A02293 | 34433590 | BMJ Open | Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes. | 2021 | Details |
| A02294 | 34433546 | BMJ Open Diabetes Res Care | Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults. | 2021 | Details |
| A02297 | 34432804 | PLoS One | Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. | 2021 | Details |
| A02301 | 34430188 | Cureus | In-Hospital Outcomes of Patients With Non-Alcoholic Fatty Liver Disease Who Underwent Percutaneous Coronary Intervention: A Nationwide Inpatient Sample Analysis. | 2021 | Details |
| A02311 | 34423721 | Expert Rev Gastroenterol Hepatol | Metabolic disorders and the risk of cholangiocarcinoma. | 2021 | Details |
| A02325 | 34418914 | Endocrinol Metab (Seoul) | High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. | 2021 | Details |
| A02330 | 34416040 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. | 2021 | Details |
| A02333 | 34414956 | Medicine (Baltimore) | Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients. | 2021 | Details |
| A02334 | 34414507 | Virchows Arch | Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. | 2021 | Details |
| A02335 | 34414181 | Front Cell Dev Biol | Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders. | 2021 | Details |
| A02339 | 34411553 | Metabolism | Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea. | 2021 | Details |
| A02343 | 34410573 | Dig Dis Sci | A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02346 | 34408183 | Sci Rep | Key features of the environment promoting liver cancer in the absence of cirrhosis. | 2021 | Details |
| A02347 | 34407600 | Diabetes Metab J | Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway. | 2021 | Details |
| A02349 | 34406410 | J Clin Endocrinol Metab | The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD. | 2022 | Details |
| A02350 | 34406397 | J Mol Cell Biol | Multi-omics profiling: the way towards precision medicine in metabolic diseases. | 2021 | Details |
| A02355 | 34405221 | Sheng Li Xue Bao | [Arachidonic acid metabolism in liver glucose and lipid homeostasis]. | 2021 | Details |
| A02360 | 34403664 | Environ Res | Lead, mercury, and cadmium exposures are associated with obesity but not with diabetes mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
| A02366 | 34401141 | Ann Med Surg (Lond) | Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study. | 2021 | Details |
| A02367 | 34400897 | Int J Med Sci | Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes. | 2021 | Details |
| A02369 | 34400217 | Metabolism | Diabetes and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02372 | 34400007 | Clin Ther | Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. | 2021 | Details |
| A02373 | 34399601 | Int J Immunopathol Pharmacol | Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice. | 2022 | Details |
| A02374 | 34399486 | Food Res Int | Protective and ameliorating effects of probiotics against diet-induced obesity: A review. | 2021 | Details |
| A02376 | 34398492 | Aliment Pharmacol Ther | Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. | 2021 | Details |
| A02377 | 34397849 | Medicine (Baltimore) | Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease. | 2021 | Details |
| A02379 | 34397640 | Eur J Gastroenterol Hepatol | The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus. | 2021 | Details |
| A02385 | 34394332 | PPAR Res | Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases. | 2021 | Details |
| A02393 | 34390493 | Eur J Clin Invest | Mushrooms on the plate: Trends towards NAFLD treatment, health improvement and sustainable diets. | 2021 | Details |
| A02402 | 34385479 | Sci Rep | Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. | 2021 | Details |
| A02411 | 34383111 | Calcif Tissue Int | Neuregulin 4 Attenuates Osteoarthritis Progression by Inhibiting Inflammation and Apoptosis of Chondrocytes in Mice. | 2021 | Details |
| A02412 | 34382947 | Am J Gastroenterol | Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02414 | 34382495 | Ann Med | Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. | 2021 | Details |
| A02418 | 34381196 | Nat Rev Endocrinol | GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. | 2021 | Details |
| A02425 | 34374782 | Inflamm Bowel Dis | The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. | 2022 | Details |
| A02433 | 34372627 | Diabetes Metab J | Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study. | 2021 | Details |
| A02450 | 34366886 | Front Physiol | Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
| A02451 | 34366846 | Front Pharmacol | Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy. | 2021 | Details |
| A02461 | 34363981 | Diabetes Metab | Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. | 2021 | Details |
| A02474 | 34360538 | Int J Mol Sci | Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. | 2021 | Details |
| A02482 | 34358793 | Curr Opin Pharmacol | Very-low-calorie ketogenic diet: An alternative to a pharmacological approach to improve glycometabolic and gonadal profile in men with obesity. | 2021 | Details |
| A02483 | 34358397 | Liver Int | Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus. | 2021 | Details |
| A02485 | 34357836 | Curr Med Res Opin | Effect of newer antihyperglycemic drugs on liver steatosis indices in patients with diabetes and obesity. | 2021 | Details |
| A02489 | 34355342 | Endocrine | Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. | 2021 | Details |
| A02490 | 34355282 | Metabolomics | Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. | 2021 | Details |
| A02495 | 34352984 | Diabetes Metab J | 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. | 2021 | Details |
| A02496 | 34352720 | Diabetes Metab Syndr | Meta-analysis of trials in non-alcoholic fatty liver disease with therapeutic interventions for metabolic syndrome. | 2021 | Details |
| A02501 | 34350196 | Front Med (Lausanne) | Prevalence and Incidence of Non-alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study. | 2021 | Details |
| A02517 | 34343577 | Metabolism | Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease. | 2021 | Details |
| A02518 | 34343274 | Endocrinology | SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD. | 2021 | Details |
| A02519 | 34342335 | Ann Acad Med Singap | New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore. | 2021 | Details |